Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population

Neurobiology of Aging

Volumn 38, Issue , 2015, Pages 218.e1-218.e2

  Fan, Tian Sin ^a   Lin, Hang I ^a   Lin, Chin Hsien ^a   Wu, Ruey Meei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Autosomal dominant; CHCHD2; Coiled coil helix coiled coil helix domain containing 2; Genetic risk; Parkinson disease

Indexed keywords

LEUCINE; PROLINE; CHCHD2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CHCHD2 GENE; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; TAIWANESE; VERY ELDERLY; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT ANALYSIS; DNA SEQUENCE; DOMINANT GENE; GENETIC ASSOCIATION STUDY; GENETICS; MUTATION; RISK; TAIWAN;

ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; EXONS; GENES, DOMINANT; GENETIC ASSOCIATION STUDIES; HUMANS; MITOCHONDRIAL PROTEINS; MUTATION; RISK; SEQUENCE ANALYSIS, DNA; TAIWAN; TRANSCRIPTION FACTORS;

EID: 84951051504     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.11.020     Document Type: Article

References (12)

1. Foo J.N., Liu J., Tan E.K. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:681-682.
2. Funayama M., Ohe K., Amo T., Furuya N., Yamaguchi J., Saiki S., Li Y., Ogaki K., Ando M., Yoshino H., Tomiyama H., Nishioka K., Hasegawa K., Saiki H., Satake W., Mogushi K., Sasaki R., Kokubo Y., Kuzuhara S., Toda T., Mizuno Y., Uchiyama Y., Ohno K., Hattori N. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015, 14:274-282.
3. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992, 42:1142-1146.
4. Iqbal Z., Toft M. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:680-681.
5. Jansen I.E., Bras J.M., Lesage S., Schulte C., Gibbs J.R., Nalls M.A., Brice A., Wood N.W., Morris H., Hardy J.A., Singleton A.B., Gasser T., Heutink P., Sharma M. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:678-679. IPDGC.
6. Lee M.J., Mata I.F., Lin C.H., Tzen K.Y., Lincoln S.J., Bounds R., Lockhart P.J., Hulihan M.M., Farrer M.J., Wu R.M. Genotype-phenotype correlates in Taiwanese patients with early-onset recessive Parkinsonism. Mov. Disord. 2009, 24:104-108.
7. Lin C.H., Tan E.K., Chen M.L., Tan L.C., Lim H.Q., Chen G.S., Wu R.M. Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 2008, 71:1727-1732.
8. Lin M.K., Farrer M.J. Genetics and genomics of Parkinson's disease. Genome Med. 2014, 6:48.
9. Liu G., Li K. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:679-680.
10. Puschmann A., Dickson D.W., Englund E., Wszolek Z.K., Ross O.A. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:679.
11. Trinh J., Farrer M.J. Advances in the genetics of Parkinson disease. Nat. Rev. Neurol. 2013, 9:445-454.
12. Wu R.M., Bounds R., Lincoln S., Hulihan M., Lin C.H., Hwu W.L., Chen J., Gwinn-Hardy K., Farrer M. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. Arch. Neurol. 2005, 62:82-87.